butabarbital decreases effects of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Intently. Coadministration of CYP3A4 inducers may perhaps minimize sufentanil ranges and efficacy, perhaps precipitating withdrawal syndrome in sufferers which have created